SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640334-22-000745
Filing Date
2022-04-13
Accepted
2022-04-13 06:05:23
Documents
8
Period of Report
2022-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A lxrp_def14a.htm DEF 14A 448150
2 lxrp_def14aimg21.jpg GRAPHIC 5590
3 lxrp_def14aimg22.jpg GRAPHIC 1478
4 lxrp_def14aimg23.jpg GRAPHIC 1589
5 lxrp_def14aimg24.jpg GRAPHIC 1604
6 lxrp_def14aimg25.jpg GRAPHIC 9941
7 lxrp_def14aimg3.jpg GRAPHIC 7792
8 lxrp_def14aimg4.jpg GRAPHIC 3721
  Complete submission text file 0001640334-22-000745.txt   493921
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 001-39874 | Film No.: 22823568
SIC: 2834 Pharmaceutical Preparations